Skip to main content
White paper

Biosimilar Utilization at 340B and Non-340B Outpatient Hospitals in the Commercial Market

By Katherine M. Holcomb and Peter Chang
17 November 2022

About the Author(s)

Peter Chang


View bio

We’re here to help

Ask the tough questions. We’re ready for them.

popup image